BioSpace News Archive

Business

Notch Therapeutics Welcomes Deepika Rajesh as VP, Stem Cell Biology & Developmental Immunology

Notch Therapeutics, Inc. is pleased to announce the appointment of Deepika Rajesh as VP, Stem Cell Biology and Developmental Immunology.

April 6, 2022
·
2 min read
FDA

BioXcel Therapeutics Announces FDA Approval of IGALMI™ (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults

BioXcel Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved IGALMI™ (dexmedetomidine) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

April 6, 2022
·
14 min read
Biotech Bay

ASLAN Pharmaceuticals to Present at the Annual Needham Virtual Healthcare Conference 2022

ASLAN Pharmaceuticals today announced that Dr Carl Firth, CEO, will present at the 21st Annual Needham Virtual Healthcare Conference.

April 6, 2022
·
1 min read
PolyPid Secures $15 Million Non-Dilutive Secured Term Loan Facility

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that the Company has entered into a secured loan agreement for up to $15 million with Kreos Capital VI LP.

April 6, 2022
·
7 min read
Business

Bio-Path Holdings Appoints Aline Sherwood to Board of Directors

Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, announced the appointment of Aline Sherwood to its Board of Directors on March 31, 2022.

April 6, 2022
·
4 min read
Deals

Universal Ibogaine Announces Frankfurt Stock Exchange Listing

Universal Ibogaine Inc. is pleased to announce that its common shares have been approved for trading on the Frankfurt Stock Exchange, or Bourse Frankfurt (the “FSE”) under the ticker symbol “JC4".

April 6, 2022
·
5 min read
Seegene’s Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

Seegene Inc. today announced that its Allplex™ RV Master Assay has received approval from Australia’s Therapeutic Goods Administration and achieved the European CE-IVD marking.

April 6, 2022
·
3 min read
BioMidwest

Oral Vaccine Boosts COVID Immunity

Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2.

April 6, 2022
·
3 min read
Business

Nevro to Report First Quarter 2022 Financial Results

Company to Host Conference Call on Wednesday, May 4, 2022 at 1:30 pm PT / 4:30 pm ET.

April 6, 2022
·
2 min read
Genetown

Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 06, 2022

Epizyme announced that the Company has granted equity awards to Jerald Korn, the Company’s Chief Operating Officer, with a grant date of April 1, 2022, as equity inducement awards outside of the Company’s 2013 Stock Incentive Plan and material to Mr. Korn’s acceptance of employment with the Company.

April 6, 2022
·
1 min read